In our robot workshop, this AI trading bot from Swing trader: Downtrend Protection v.2 (TA) was a top performer, generated 17% for PFE over the past six months.
Pfizer (PFE) is a well-known pharmaceutical company with a market capitalization of over $200 billion. Over the past six months, an AI trading robot named Swing trader: Downtrend Protection v.2 (TA) has generated a solid 17% return on PFE. This is a promising result and highlights the potential benefits of utilizing AI and machine learning algorithms to make trading decisions.
However, it is important to note that past performance is not a guarantee of future results. Even with a successful track record, it is crucial to continue monitoring the stock's momentum and any other relevant indicators to ensure that trading decisions are based on the most up-to-date information.
The Momentum Indicator is one such tool that traders can use to gauge the direction of a stock's price movement. On April 18, 2023, PFE's Momentum Indicator moved below the 0 level, which could signal a new downward trend for the stock. This is a cause for concern for traders who may want to consider selling the stock or exploring put options.
To gain a better understanding of how PFE has historically responded to this indicator turning negative, Tickeron's A.I.dvisor analyzed 81 similar instances. The results show that in 50 of these cases, the stock moved further down in the following days. This suggests that there is a 62% chance of a decline in the coming days.
It is important to note that while this information is useful for traders, it is only one piece of the puzzle. Other factors such as earnings reports, news events, and market sentiment can also influence a stock's performance. Therefore, it is crucial to conduct thorough research and analysis before making any trading decisions.
In terms of earnings results, Pfizer recently reported its first-quarter 2023 financial results. The company beat earnings estimates with adjusted earnings per share of $0.98, compared to the expected $0.96. Revenue for the quarter was $16.7 billion, which also exceeded expectations. This positive earnings report may have helped to support PFE's price in the short-term, but traders should continue to monitor the stock's momentum and other relevant indicators for any potential shifts in market sentiment.
Overall, while the AI trading robot's 17% return on PFE over the past six months is an encouraging sign, it is crucial to remain vigilant and continuously analyze relevant indicators to make informed trading decisions.
The RSI Indicator for PFE moved out of oversold territory on May 22, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In of the 36 cases the stock moved higher. This puts the odds of a move higher at .
The Moving Average Convergence Divergence (MACD) for PFE just turned positive on May 22, 2023. Looking at past instances where PFE's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PFE advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where PFE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on June 06, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on PFE as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
PFE moved below its 50-day moving average on May 24, 2023 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PFE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PFE broke above its upper Bollinger Band on May 23, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PFE entered a downward trend on May 23, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.174) is normal, around the industry mean (6.329). P/E Ratio (7.669) is within average values for comparable stocks, (31.163). Projected Growth (PEG Ratio) (1.110) is also within normal values, averaging (3.412). PFE has a moderately high Dividend Yield (0.042) as compared to the industry average of (0.027). P/S Ratio (2.395) is also within normal values, averaging (4.100).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PFE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of vaccines and injectable biologic medicines
A.I.dvisor indicates that over the last year, PFE has been loosely correlated with JNJ. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then JNJ could also see price increases.